Annual FCF
-$18.70 M
+$2.28 M+10.88%
31 December 2023
Summary:
Cardiol Therapeutics annual free cash flow is currently -$18.70 million, with the most recent change of +$2.28 million (+10.88%) on 31 December 2023. During the last 3 years, it has fallen by -$11.85 million (-173.17%). CRDL annual FCF is now -1733.69% below its all-time high of -$1.02 million, reached on 01 December 2017.CRDL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$5.72 M
-$2.31 M-67.50%
30 September 2024
Summary:
Cardiol Therapeutics quarterly free cash flow is currently -$5.72 million, with the most recent change of -$2.31 million (-67.50%) on 30 September 2024. Over the past year, it has dropped by -$3.15 million (-122.27%). CRDL quarterly FCF is now -2034.27% below its all-time high of -$268.20 thousand, reached on 01 March 2018.CRDL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$18.99 M
-$3.15 M-19.88%
30 September 2024
Summary:
Cardiol Therapeutics TTM free cash flow is currently -$18.99 million, with the most recent change of -$3.15 million (-19.88%) on 30 September 2024. Over the past year, it has increased by +$4.72 million (+19.91%). CRDL TTM FCF is now -6979.53% below its all-time high of -$268.20 thousand, reached on 01 March 2018.CRDL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.9% | -122.3% | +19.9% |
| 3 y3 years | -173.2% | -18.9% | -9.1% |
| 5 y5 years | -122.1% | -211.9% | -45.0% |
CRDL Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -173.2% | +10.9% | -426.8% | +41.1% | -30.8% | +19.9% |
| 5 y | 5 years | -173.2% | +10.9% | -618.8% | +41.1% | -179.7% | +19.9% |
| alltime | all time | -1733.7% | +10.9% | -2034.3% | +41.1% | -6979.5% | +19.9% |
Cardiol Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.72 M(+67.5%) | -$18.99 M(+19.9%) |
| June 2024 | - | -$3.42 M(-33.5%) | -$15.84 M(-3.7%) |
| Mar 2024 | - | -$5.14 M(+9.0%) | -$16.45 M(-12.0%) |
| Dec 2023 | -$18.70 M(-10.9%) | -$4.71 M(+82.9%) | -$18.70 M(-21.1%) |
| Sept 2023 | - | -$2.58 M(-36.0%) | -$23.71 M(+6.7%) |
| June 2023 | - | -$4.03 M(-45.5%) | -$22.22 M(+10.3%) |
| Mar 2023 | - | -$7.38 M(-24.0%) | -$20.13 M(-4.0%) |
| Dec 2022 | -$20.98 M(+11.7%) | -$9.72 M(+794.6%) | -$20.98 M(+44.5%) |
| Sept 2022 | - | -$1.09 M(-44.1%) | -$14.52 M(-20.4%) |
| June 2022 | - | -$1.94 M(-76.4%) | -$18.24 M(-14.8%) |
| Mar 2022 | - | -$8.23 M(+152.5%) | -$21.43 M(+14.1%) |
| Dec 2021 | -$18.79 M | - | - |
| Dec 2021 | - | -$3.26 M(-32.3%) | -$18.79 M(+8.0%) |
| Sept 2021 | - | -$4.81 M(-6.1%) | -$17.40 M(+16.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$5.12 M(-8.3%) | -$14.94 M(+40.8%) |
| Mar 2021 | - | -$5.59 M(+198.3%) | -$10.61 M(+55.0%) |
| Dec 2020 | -$6.84 M(-23.0%) | -$1.87 M(-20.2%) | -$6.84 M(-6.3%) |
| Sept 2020 | - | -$2.35 M(+194.9%) | -$7.30 M(+7.6%) |
| June 2020 | - | -$796.40 K(-56.4%) | -$6.79 M(-11.4%) |
| Mar 2020 | - | -$1.82 M(-21.8%) | -$7.66 M(-13.8%) |
| Dec 2019 | -$8.89 M(+5.7%) | -$2.33 M(+27.1%) | -$8.89 M(-32.1%) |
| Sept 2019 | - | -$1.84 M(+9.8%) | -$13.09 M(+5.1%) |
| June 2019 | - | -$1.67 M(-45.3%) | -$12.46 M(+11.3%) |
| Mar 2019 | - | -$3.05 M(-53.2%) | -$11.20 M(+33.1%) |
| Dec 2018 | -$8.42 M(+725.5%) | -$6.53 M(+441.7%) | -$8.42 M(+346.5%) |
| Sept 2018 | - | -$1.21 M(+193.3%) | -$1.89 M(+177.5%) |
| June 2018 | - | -$411.10 K(+53.3%) | -$679.30 K(+153.3%) |
| Mar 2018 | - | -$268.20 K | -$268.20 K |
| Dec 2017 | -$1.02 M | - | - |
FAQ
- What is Cardiol Therapeutics annual free cash flow?
- What is the all time high annual FCF for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual FCF year-on-year change?
- What is Cardiol Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly FCF year-on-year change?
- What is Cardiol Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Cardiol Therapeutics?
- What is Cardiol Therapeutics TTM FCF year-on-year change?
What is Cardiol Therapeutics annual free cash flow?
The current annual FCF of CRDL is -$18.70 M
What is the all time high annual FCF for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual free cash flow is -$1.02 M
What is Cardiol Therapeutics annual FCF year-on-year change?
Over the past year, CRDL annual free cash flow has changed by +$2.28 M (+10.88%)
What is Cardiol Therapeutics quarterly free cash flow?
The current quarterly FCF of CRDL is -$5.72 M
What is the all time high quarterly FCF for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly free cash flow is -$268.20 K
What is Cardiol Therapeutics quarterly FCF year-on-year change?
Over the past year, CRDL quarterly free cash flow has changed by -$3.15 M (-122.27%)
What is Cardiol Therapeutics TTM free cash flow?
The current TTM FCF of CRDL is -$18.99 M
What is the all time high TTM FCF for Cardiol Therapeutics?
Cardiol Therapeutics all-time high TTM free cash flow is -$268.20 K
What is Cardiol Therapeutics TTM FCF year-on-year change?
Over the past year, CRDL TTM free cash flow has changed by +$4.72 M (+19.91%)